{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:32:04Z","timestamp":1778200324449,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:00:00Z","timestamp":1562716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.euf.2019.07.001","type":"journal-article","created":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T01:07:11Z","timestamp":1562980031000},"page":"722-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Current Disease Management of Primary Urethral Carcinoma"],"prefix":"10.1016","volume":"5","author":[{"given":"Florian","family":"Janisch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6603-6319","authenticated-orcid":false,"given":"Mohammad","family":"Abufaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harun","family":"Fajkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6116-543X","authenticated-orcid":false,"given":"Takehiro","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Nyirady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2019.07.001_bib0005","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejca.2011.10.031","article-title":"Incidence and survival of rare urogenital cancers in Europe","volume":"48","author":"Visser","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.euf.2019.07.001_bib0010","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.ejca.2011.08.008","article-title":"Rare cancers are not so rare: the rare cancer burden in Europe","volume":"47","author":"Gatta","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.euf.2019.07.001_bib0015","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.urology.2006.08.1057","article-title":"Incidence of primary urethral carcinoma in the United States","volume":"68","author":"Swartz","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.euf.2019.07.001_bib0020","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.urolonc.2009.07.020","article-title":"Bladder cancer in the elderly","volume":"27","author":"Shariat","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2019.07.001_bib0025","first-page":"478","article-title":"Urethral squamous cell carcinoma associated with urethral stricture and urethroplasty","volume":"20","author":"Van de Voorde","year":"1994","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.euf.2019.07.001_bib0030","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.juro.2008.08.040","article-title":"Urethral diverticula in 90 female patients: a study with emphasis on neoplastic alterations","volume":"180","author":"Thomas","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2019.07.001_bib0035","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0090-4295(96)00246-4","article-title":"Detection of human papillomavirus DNA in primary squamous cell carcinoma of the male urethra","volume":"48","author":"Cupp","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.euf.2019.07.001_bib0040","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1177\/1557988318782095","article-title":"Lichen sclerosus accompanied by urethral squamous cell carcinoma: a retrospective study from a urethral referral center","volume":"12","author":"Guo","year":"2018","journal-title":"Am J Mens Health"},{"key":"10.1016\/j.euf.2019.07.001_bib0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.humpath.2017.08.006","article-title":"Carcinoma of the urethra","volume":"72","author":"Zhang","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.euf.2019.07.001_bib0050","series-title":"The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis","author":"Wells","year":"2000"},{"issue":"670","key":"10.1016\/j.euf.2019.07.001_bib0055","first-page":"e15","article-title":"Contemporary practice patterns and survival outcomes for locally advanced urethral malignancies: a National Cancer Database analysis","volume":"35","author":"Cahn","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2019.07.001_bib0060","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.urology.2012.02.058","article-title":"Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysis","volume":"80","author":"Champ","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.euf.2019.07.001_bib0065","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.urolonc.2012.01.011","article-title":"Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists","volume":"31","author":"Dayyani","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2019.07.001_bib0070","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/annonc\/mdv230","article-title":"Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma","volume":"26","author":"Gakis","year":"2015","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.euf.2019.07.001_bib0075","article-title":"The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma","volume":"36","author":"Gakis","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2019.07.001_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2018.05.012","article-title":"Survival outcomes associated with female primary urethral carcinoma: review of a single institutional experience","volume":"16","author":"Peyton","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euf.2019.07.001_bib0085","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/cncr.25787","article-title":"Prognostic factors in male urethral cancer","volume":"117","author":"Rabbani","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.euf.2019.07.001_bib0090","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijrobp.2018.06.007","article-title":"Optimizing the role of surgery and radiation therapy in urethral cancer based on histology and disease extent","volume":"102","author":"Son","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euf.2019.07.001_bib0095","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.2147\/OTT.S139252","article-title":"Sex-related differences in clinicopathological features and survival of patients with primary urethral carcinoma: a population-based study","volume":"10","author":"Wei","year":"2017","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.euf.2019.07.001_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred Reporting Items for Systematic Review and Meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.euf.2019.07.001_bib0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00345-012-0882-5","article-title":"Primary urethral carcinoma in females: an epidemiologic study on demographical factors, histological types, tumour stage and survival","volume":"31","author":"Derksen","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2019.07.001_bib0110","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.eururo.2013.03.044","article-title":"EAU guidelines on primary urethral carcinoma","volume":"64","author":"Gakis","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2019.07.001_bib0115","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.6004\/jnccn.2017.0156","article-title":"Bladder cancer, version 5.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Spiess","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.euf.2019.07.001_bib0120","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/his.13025","article-title":"Immunochemical and molecular assessment of urothelial neoplasms and aspects of the 2016 World Health Organization classification","volume":"69","author":"Comperat","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.euf.2019.07.001_bib0125","series-title":"TNM classification of malignant tumours","first-page":"208","year":"2017"},{"key":"10.1016\/j.euf.2019.07.001_bib0130","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0090-4295(98)00199-X","article-title":"Management of primary urethral cancer","volume":"52","author":"Gheiler","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.euf.2019.07.001_bib0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.urology.2003.08.007","article-title":"Role of voided urine cytology in diagnosing primary urethral carcinoma","volume":"63","author":"Touijer","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.euf.2019.07.001_bib0140","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/S0022-5347(05)66352-5","article-title":"The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer","volume":"165","author":"Donat","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2019.07.001_bib0145","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jjco\/28.6.357","article-title":"Transitional cell carcinoma of the urethra in men and women associated with bladder cancer","volume":"28","author":"Kakizoe","year":"1998","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.euf.2019.07.001_bib0150","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000448335","article-title":"Oncological outcomes of patients with concomitant bladder and urethral carcinoma","volume":"97","author":"Gakis","year":"2016","journal-title":"Urol Int"},{"key":"10.1016\/j.euf.2019.07.001_bib0155","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00345-015-1583-7","article-title":"Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma","volume":"34","author":"Gakis","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2019.07.001_bib0160","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00192-015-2790-x","article-title":"MRI of female urethra and periurethral pathologies","volume":"27","author":"Itani","year":"2016","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.euf.2019.07.001_bib0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1464-410X.2007.06901.x","article-title":"Penile-preserving surgery for male distal urethral carcinoma","volume":"100","author":"Smith","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2019.07.001_bib0170","doi-asserted-by":"crossref","first-page":"e1131","DOI":"10.1016\/j.clgc.2017.07.006","article-title":"Diagnosing distal urethral carcinomas in men might be only the tip of the iceberg","volume":"15","author":"Torbrand","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euf.2019.07.001_bib0175","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ucl.2010.04.011","article-title":"Surgery for urethral cancer","volume":"37","author":"Karnes","year":"2010","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.euf.2019.07.001_bib0180","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3346\/jkms.2015.30.8.1143","article-title":"Survival outcomes and predictive factors for female urethral cancer: Long-term experience with Korean patients","volume":"30","author":"Kang","year":"2015","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.euf.2019.07.001_bib0185","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1002\/1097-0142(19930515)71:10<3102::AID-CNCR2820711034>3.0.CO;2-2","article-title":"Primary carcinoma of the female urethra. Results of radiation therapy","volume":"71","author":"Garden","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.euf.2019.07.001_bib0190","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1078-1439(03)00174-1","article-title":"Surgical treatment for local control of female urethral carcinoma","volume":"22","author":"Dimarco","year":"2004","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2019.07.001_bib0195","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11255-009-9618-x","article-title":"Urethral diverticular carcinoma: an overview of current trends in diagnosis and management","volume":"42","author":"Ahmed","year":"2010","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.euf.2019.07.001_bib0200","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ucl.2016.06.011","article-title":"Management of proximal primary urethral cancer: should multidisciplinary therapy be the gold standard?","volume":"43","author":"Zinman","year":"2016","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.euf.2019.07.001_bib0205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/bju.12630","article-title":"Management of advanced primary urethral carcinomas","volume":"114","author":"Dayyani","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2019.07.001_bib0210","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0090-4295(94)90242-9","article-title":"Therapy and prognosis for male anterior urethral carcinoma: an update","volume":"43","author":"Dinney","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.euf.2019.07.001_bib0215","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0090-4295(98)00659-1","article-title":"Male urethral carcinoma: analysis of treatment outcome","volume":"53","author":"Dalbagni","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.euf.2019.07.001_bib0220","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.urology.2009.07.1296","article-title":"A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma","volume":"75","author":"Lughezzani","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.euf.2019.07.001_bib0225","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0022-5347(17)58546-8","article-title":"Experience with primary carcinoma of the male urethra","volume":"117","author":"Ray","year":"1977","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2019.07.001_bib0230","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2019.07.001_bib0235","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1442-2042.2006.01392.x","article-title":"Clinical outcome of 36 male patients with primary urethral carcinoma: a single center experience","volume":"13","author":"Thyavihally","year":"2006","journal-title":"Int J Urol"},{"key":"10.1016\/j.euf.2019.07.001_bib0240","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.juro.2007.09.068","article-title":"Coordinated chemoradiation therapy with genital preservation for the treatment of primary invasive carcinoma of the male urethra","volume":"179","author":"Cohen","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2019.07.001_bib0245","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.eururo.2014.02.038","article-title":"Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review","volume":"66","author":"Ploussard","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2019.07.001_bib0250","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.seminoncol.2012.01.002","article-title":"Chemotherapy of squamous cell carcinoma of the skin","volume":"39","author":"DeConti","year":"2012","journal-title":"Semin Oncol"},{"key":"10.1016\/j.euf.2019.07.001_bib0255","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.eururo.2014.09.007","article-title":"Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer","volume":"67","author":"Zargar","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2019.07.001_bib0260","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1046\/j.1464-410X.1998.00878.x","article-title":"Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategy","volume":"82","author":"Dalbagni","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.euf.2019.07.001_bib0265","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0022-5347(17)38047-3","article-title":"Transitional cell carcinoma of the prostate","volume":"146","author":"Matzkin","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2019.07.001_bib0270","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0022-5347(05)64056-6","article-title":"Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases","volume":"169","author":"Njinou Ngninkeu","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2019.07.001_bib0275","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.eururo.2005.12.019","article-title":"Intravesical instillations with bacillus Calmette-Guerin for the treatment of carcinoma in situ involving prostatic ducts","volume":"49","author":"Palou Redorta","year":"2006","journal-title":"Eur Urol"},{"issue":"1 Suppl","key":"10.1016\/j.euf.2019.07.001_bib0280","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.urology.2006.05.059","article-title":"Urothelial carcinoma of the prostate","volume":"69","author":"Palou","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.euf.2019.07.001_bib0285","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00005392-199501000-00020","article-title":"Intravesical bacillus Calmette-Guerin for treatment of superficial transitional cell carcinoma of the prostatic urethra in association with carcinoma of the bladder","volume":"153","author":"Schellhammer","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2019.07.001_bib0290","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1464-410X.2008.08210.x","article-title":"Prostatic urothelial carcinoma: is transurethral prostatectomy necessary before bacillus Calmette-Guerin immunotherapy?","volume":"103","author":"Gofrit","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2019.07.001_bib0295","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10147-012-0508-3","article-title":"Clinical outcomes of urothelial carcinoma of the prostate detected in radical cystectomy specimens","volume":"19","author":"Ichihara","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.euf.2019.07.001_bib0300","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/bju.12486","article-title":"Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy","volume":"114","author":"Knoedler","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2019.07.001_bib0305","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0022-5347(17)36068-8","article-title":"An adequate sampling of the prostate to identify prostatic involvement by urothelial carcinoma in bladder cancer patients","volume":"149","author":"Sakamoto","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2019.07.001_bib0310","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0022-5347(01)66762-4","article-title":"The prostate involvement as prognostic factor in patients with superficial bladder tumors","volume":"154","author":"Solsona","year":"1995","journal-title":"J Urol"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456919301725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456919301725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:49:53Z","timestamp":1762498193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456919301725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S2405456919301725"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2019.07.001","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Disease Management of Primary Urethral Carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2019.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Association of Urology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}